About Sanyou Biopharmaceuticals：
Sanyou Biopharmaceuticals Co., Ltd. is a world-leading high-tech biotechnology enterprise focusing on R&D and services of innovative biologic drugs. Sanyou has built the 4C business patterns that integrate “differentiated CRO, integrated CDO, innovative CPO and characteristic CRS”, to accomplish the mission “to make the R&D easy for innovative biologics”. Sanyou has established an integrated innovative biologic drug R&D laboratory with advanced facilities, and has a professional team with the majority holding a Ph.D. or master degree. Sanyou has built three industry-leading innovative technology platforms featured by “super-trillion, integration, and intelligence” , which are comprised of more than 50 sub-platforms with the core innovative super-trillion phage display platform, and supported by platforms of material preparation, biologics discovery, molecule optimization, in vitro and in vivo efficacy, production cell line construction, upstream and downstream process development, preclinical R&D, industrialization development, etc.
During the rapid growth of the company, Sanyou has always adhered to the operation management strategy of “platform, project, responsibility, process, standardization and refinement”, actively introduced international advanced management mode in project management, and established a sound R & D quality management system. In order to continue to bring more valuable services to customers and partners, Sanyou Biology has long paid attention to digital transformation, hoping to further enhance the level of collaboration, automation and integration of R&D management by digital means, and accelerate business innovation.
Challenges & Needs:
Before collaborating with Neotrident, Sanyou has already started to using digital R&D management systems such as ELN. With a rapid growth in its business, Sanyou’s needs for ELN has also changed:
- With the continuous improvement of the level of drug research and development, new requirements for ELN are keep emerging. An ELN product can only meet the needs of traditional experimental data management. without continuous updates, will not be able to adapt to the development of business.
- With the increase in the number of projects, a single ELN can no longer meet the complex project management needs, and a professional R&D project management system is urgently needed. Therefore, a unified platform with multi-system module integration for the whole process of drug research and development can better meet the practical needs.
- Due to the particularity of biological experiments, ELN often faces the needs of managing a large number of Excel files and submitting samples for inspection. Thus, only an ELN product that can provide more flexible processing methods will be able to fulfil the strong demands of researchers for convenient use.
Our Solutions:
After various investigations, Sanyou Biology finally selected a new SaaS-based electronic lab record developed by Neotrident Technology, the iLabPower ELN, to replace the original ELN system that was locally deployed by other providers, and simultaneously launched R&D project management system (iLabPower PM) to cooperate with ELN. The system went from the start of implementation to fully operatable, for just less than 2 weeks.
Director of Sanyou Biopharmaceuticals QA department said: “The iLabPower platform has a simple and user-friendly interface, and smooth during use, which has been commonly admitted by users. The SaaS-based deployment allows products to truly iterate quickly, that greatly improving the agility of products and services. Neotrident also regularly organize their professional teams to communicate with us on technical matters，in order to understand our actual business needs. ‘Cloud deployment + localized technical support’ is really efficient.”
With the vision of “using innovative biologic drugs to improve the quality of human life” and the mission of “making the world not difficult to do innovative biologic drugs”, Sanyou Biopharmaceuticals has constantly achieved innovation and breakthrough, and has become the mainstay in the field of innovative biologic drug research and development and service! It is believed that through the blessing of digital transformation, Sanyou Biopharmaceuticals Biology will launch innovative, excellent and reliable new technologies, new products, new services and new scenarios with a stronger innovation drive!
